Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 418–419 (2006)Cite this article

boxed-textIwanaga Y et al. (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47: 742–748

Normal BNP or N-terminal pro-BNP levels in patients with exertional dyspnea reliably exclude significant systolic dysfunction, but are less accurate in detecting or excluding predominant diastolic dysfunction

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hunt SA et al. (2005) ACC/AHA guidelines update for the diagnosis and management of chronic heart failure in the adult. Circulation 112: e154–e235

    Article  Google Scholar 

  2. Dahlstöm U (2004) Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 6: 281–287

    Article  Google Scholar 

  3. Hartmann F et al. (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure. Circulation 110: 1780–1786

    Article  CAS  Google Scholar 

  4. Kögler H et al.: Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+-ATPase expression. Circulation, in press

  5. Valle R et al. (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11: 498–503

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Department of Cardiology and Pneumology, Professor of Medicine and Cardiology, and Head of the Laboratories of Experimental Cardiology, University of Göttingen, Göttingen, Germany

    Burkert Pieske

Authors
  1. Burkert Pieske
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burkert Pieske.

Ethics declarations

Competing interests

The University of Göttingen, where B Pieske works, has received research funding from Roche Diagnostics, Germany.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pieske, B. Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure?. Nat Rev Cardiol 3, 418–419 (2006). https://doi.org/10.1038/ncpcardio0606

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0606

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing